-
Laws/regulations involving reimbursement for injury-induced medical expense i...
Laws/regulations involving reimbursement for injury-induced medical expense in Chinese social medical insurance schemes. -
Comparison of OOP proportion between 2008 and 2011.
Comparison of OOP proportion between 2008 and 2011. -
IC, IE & ICERs for the base case scenario (GOG-0218 (st.IV), ICON7 (high risk...
IC, IE & ICERs for the base case scenario (GOG-0218 (st.IV), ICON7 (high risk), OCEANS, and AURELIA). -
Mean treatment duration and bevacizumab treatment costs.
Mean treatment duration and bevacizumab treatment costs. -
Causes of hospitalization among urban and rural residents from 2003 to 2011, ...
Causes of hospitalization among urban and rural residents from 2003 to 2011, N (%). -
Legislative documents concerning social medical insurance reimbursement of in...
Legislative documents concerning social medical insurance reimbursement of injury-induced medical expenses, number (percentage). -
Reimbursement for injury-induced medical expense in Chinese social medical in...
Reimbursement for injury-induced medical expense in Chinese social medical insurance laws/regulations, number (percentage). -
Average proportion of CHE before and after NCMS reimbursement policies.
Average proportion of CHE before and after NCMS reimbursement policies. -
r37980778c78--9ca6b1f9973d940fbdad206bc26355b3
Abbreviation: HDC, hospitalization direct cost; HIC, hospitalization indirect cost; CS, consumer spending; RMB, Renminbi. Medical expenditure of urban and rural respondents who... -
r37980778c78--a63e6918d0f2fcf0c0c39fb14005a724
BackgroundThe New Rural Cooperative Medical Scheme (NCMS) includes a maternal care benefits package that is associated with increasing maternal health services. The local... -
Demographic characteristics of the respondents from three national surveys.
Demographic characteristics of the respondents from three national surveys. -
r37980778c78--d5d7365668e43076c03f3f05e307f43b
Changes of the urban-rural disparity in hospitalization rate from 2003 to 2011. -
r37980778c78--fa0975f52c4b07cab10a08d633209409
Notes: ‘NA’ = not applicable; ‘1’ = compliant with methodological item; ‘0’ = not compliant with methodological item. [3]. -
r37980778c78--a0d8164232c266baf962d26efa98a8dd
Demographic and disease characteristics of the study population. -
r37980778c78--9204f1ba0aeb1cfe5c742fda76a6327c
Eligible patient population and bevacizumab treatment schedules in 4 peer-reviewed RCTs.